A recent study found that among women with BRCA1 and BRCA2 mutations, oral contraceptive use: 🧬 Increased risk of breast cancer with proportionate increases of 3% for each year of hormonal contraceptive use among BRCA1 carriers. 🧬 No association seen for BRCA2 carriers. 📈 Why is this important? • It would be important to discuss this information with young BRCA1 carriers as they make choices about contraception and preventive removal of the ovaries and fallopian tubes. Read the full article to learn more at: https://lnkd.in/edg62ndx Reference: Phillips, et al. J Clin Oncol. 2024:JCO2400176. PMID: 39356978. #ICARE #InheritedCancerRegistry #InheritedCancer #HereditaryCancer #Cancer #BreastCancer #BreastCancerRisk #HereditaryBreastCancer #OvarianCancer #OvarianCancerRisk #OralContraceptives #BirthControl #CancerGenetics #GeneticTesting #BRCA #BRCA1 #BRCA2 #CancerRisks #CancerRiskManagement #CancerPrevention #CancerScreening #CancerRiskReduction
